gadolinium dtpa has been researched along with Scleroderma, Limited in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Karabela, G; Katsifis, G; Kolovou, G; Koutsogeorgopoulou, L; Markousis-Mavrogenis, G; Mavrogeni, S; Noutsias, M; Plastiras, S; Raftakis, J; Stavropoulos, E | 1 |
1 other study(ies) available for gadolinium dtpa and Scleroderma, Limited
Article | Year |
---|---|
Silent myocarditis in systemic sclerosis detected by cardiovascular magnetic resonance using Lake Louise criteria.
Topics: Adult; Asymptomatic Diseases; Biomarkers; Blood Sedimentation; C-Reactive Protein; Contrast Media; Female; Fibrosis; Gadolinium DTPA; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Middle Aged; Myocarditis; Myocardium; Predictive Value of Tests; Scleroderma, Diffuse; Scleroderma, Limited; Time Factors; Treatment Outcome; Troponin T; Ventricular Function, Left; Ventricular Function, Right | 2017 |